Edward Dabrowski

689 total citations
30 papers, 465 citations indexed

About

Edward Dabrowski is a scholar working on Neurology, Psychiatry and Mental health and Rehabilitation. According to data from OpenAlex, Edward Dabrowski has authored 30 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 21 papers in Psychiatry and Mental health and 11 papers in Rehabilitation. Recurrent topics in Edward Dabrowski's work include Cerebral Palsy and Movement Disorders (21 papers), Botulinum Toxin and Related Neurological Disorders (20 papers) and Stroke Rehabilitation and Recovery (11 papers). Edward Dabrowski is often cited by papers focused on Cerebral Palsy and Movement Disorders (21 papers), Botulinum Toxin and Related Neurological Disorders (20 papers) and Stroke Rehabilitation and Recovery (11 papers). Edward Dabrowski collaborates with scholars based in United States, Germany and Poland. Edward Dabrowski's co-authors include Florian Heinen, Ingo Borggraefe, Andreas Meyer‐Heim, Corinne Ammann‐Reiffer, Michael A. Nigro, Steffen Berweck, Sarah Smathers, Felix H. Sennhauser, John Schafer and Mauricio R. Delgado and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and PEDIATRICS.

In The Last Decade

Edward Dabrowski

26 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Dabrowski United States 10 330 286 142 77 54 30 465
Corinne Bleyenheuft Belgium 13 299 0.9× 214 0.7× 219 1.5× 41 0.5× 26 0.5× 17 475
Simon‐Henri Schless Belgium 13 288 0.9× 210 0.7× 46 0.3× 63 0.8× 66 1.2× 29 382
Karel G.B. Maathuis Netherlands 8 185 0.6× 60 0.2× 31 0.2× 75 1.0× 41 0.8× 9 303
N. Tenore Italy 9 238 0.7× 44 0.2× 46 0.3× 32 0.4× 51 0.9× 15 362
Eugène Rameckers Belgium 7 181 0.5× 54 0.2× 45 0.3× 98 1.3× 59 1.1× 25 289
Belén Moliner Spain 9 58 0.2× 107 0.4× 88 0.6× 32 0.4× 10 0.2× 24 390
Vasiliki Darsaklis Canada 9 212 0.6× 33 0.1× 83 0.6× 166 2.2× 17 0.3× 10 374
Alaa I. Ibrahim Saudi Arabia 12 72 0.2× 49 0.2× 28 0.2× 20 0.3× 114 2.1× 43 386
Clarissa Crone Denmark 8 115 0.3× 185 0.6× 87 0.6× 8 0.1× 29 0.5× 14 360
Maurizio Bejor Italy 12 37 0.1× 197 0.7× 12 0.1× 38 0.5× 102 1.9× 36 374

Countries citing papers authored by Edward Dabrowski

Since Specialization
Citations

This map shows the geographic impact of Edward Dabrowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Dabrowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Dabrowski more than expected).

Fields of papers citing papers by Edward Dabrowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Dabrowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Dabrowski. The network helps show where Edward Dabrowski may publish in the future.

Co-authorship network of co-authors of Edward Dabrowski

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Dabrowski. A scholar is included among the top collaborators of Edward Dabrowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Dabrowski. Edward Dabrowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salama, Rafik, et al.. (2024). Longitudinal Retrospective Study of a Wearable NMES System to Determine the Effects on Arm Usage in Hemiparetic and Hemiplegic Patients. JPO Journal of Prosthetics and Orthotics. 37(1). 53–63.
2.
Bonfert, Michaela, Florian Heinen, Petr Kaňovský, et al.. (2022). Spasticity-related pain in children/adolescents with cerebral palsy. Part 2: IncobotulinumtoxinA efficacy results from a pooled analysis. Journal of Pediatric Rehabilitation Medicine. 16(1). 83–98. 5 indexed citations
3.
Dursun, Nigar, Marcin Bonikowski, Edward Dabrowski, et al.. (2022). Goal Attainment after Treatment with Abobotulinumtoxina and a Tailored Home Therapy Programme in Children with Upper Limb Spasticity: Descriptive, Exploratory Analysis of a Large Randomized, Controlled Study. Journal of Rehabilitation Medicine. 54. jrm00349–jrm00349. 1 indexed citations
4.
Kaňovský, Petr, Florian Heinen, A. Sebastian Schroeder, et al.. (2021). Safety and efficacy of repeat long-term incobotulinumtoxinA treatment for lower limb or combined upper/lower limb spasticity in children with cerebral palsy. Journal of Pediatric Rehabilitation Medicine. 15(1). 113–127. 9 indexed citations
5.
6.
Oleszek, Joyce, Ann Tilton, Nigar Dursun, et al.. (2021). Muscle Selection and Dosing in a Phase 3, Pivotal Study of AbobotulinumtoxinA Injection in Upper Limb Muscles in Children With Cerebral Palsy. Frontiers in Neurology. 12. 728615–728615. 3 indexed citations
7.
8.
Dabrowski, Edward, Henry G. Chambers, Deborah Gaebler‐Spira, et al.. (2021). IncobotulinumtoxinA Efficacy/Safety in Upper-Limb Spasticity in Pediatric Cerebral Palsy: Randomized Controlled Trial. Pediatric Neurology. 123. 10–20. 9 indexed citations
9.
Dursun, Nigar, Marcin Bonikowski, Edward Dabrowski, et al.. (2019). Efficacy of Repeat AbobotulinumtoxinA (Dysport®) Injections in Improving Gait in Children with Spastic Cerebral Palsy. Developmental Neurorehabilitation. 23(6). 368–374. 11 indexed citations
10.
Dabrowski, Edward, Marcin Bonikowski, Mark Gormley, et al.. (2018). AbobotulinumtoxinA Efficacy and Safety in Children With Equinus Foot Previously Treated With Botulinum Toxin. Pediatric Neurology. 82. 44–49. 4 indexed citations
11.
Heinen, Florian, Petr Kaňovský, A. Sebastian Schroeder, et al.. (2018). Efficacy and safety of incobotulinumtoxinA for lower-limb spasticity in children and adolescents with cerebral palsy. Toxicon. 156. S44–S44. 3 indexed citations
12.
Delgado, Mauricio R., Marcin Bonikowski, Edward Dabrowski, et al.. (2017). Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy. Journal of Child Neurology. 32(13). 1058–1064. 25 indexed citations
13.
14.
Delgado, Mauricio R., Ann Tilton, Barry S. Russman, et al.. (2016). AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial. PEDIATRICS. 137(2). e20152830–e20152830. 54 indexed citations
15.
Borggraefe, Ingo, Edward Dabrowski, Corinne Ammann‐Reiffer, et al.. (2010). Robotic-assisted treadmill therapy improves walking and standing performance in children and adolescents with cerebral palsy. European Journal of Paediatric Neurology. 14(6). 496–502. 110 indexed citations
16.
Meyer‐Heim, Andreas, Corinne Ammann‐Reiffer, John Schafer, et al.. (2009). Improvement of walking abilities after robotic-assisted locomotion training in children with cerebral palsy. Archives of Disease in Childhood. 94(8). 615–620. 102 indexed citations
17.
Dabrowski, Edward, et al.. (2006). Botulinum Toxin Therapy in Children. 4 indexed citations
18.
Dabrowski, Edward, et al.. (2005). Botulinum toxin as a novel treatment for self-mutilation in Lesch–Nyhan syndrome. Developmental Medicine & Child Neurology. 47(9). 636–636. 35 indexed citations
19.
Dabrowski, Edward, et al.. (2005). Botulinum toxin as a novel treatment for self‐mutilation in Lesch—Nyhan syndrome. Developmental Medicine & Child Neurology. 47(9). 636–639. 18 indexed citations
20.
Selcen, Duygu, et al.. (2000). High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis. Pediatric Neurology. 22(1). 40–43. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corinne Bleyenheuft Breakdown of academic impact, for papers by Simon‐Henri Schless Breakdown of academic impact, for papers by Karel G.B. Maathuis Breakdown of academic impact, for papers by N. Tenore Breakdown of academic impact, for papers by Eugène Rameckers Breakdown of academic impact, for papers by Belén Moliner Breakdown of academic impact, for papers by Vasiliki Darsaklis Breakdown of academic impact, for papers by Alaa I. Ibrahim Breakdown of academic impact, for papers by Clarissa Crone Breakdown of academic impact, for papers by Maurizio Bejor
Rankless by CCL
2026